RxDoctor Payments Data

Brenda Porter

Neurology with Special Qualifications in Child Neurology · Palo Alto, CANPI 1346256583

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,358 of the $2,469 with a category attached, or 95.5%. Every reported general payment came from a single manufacturer, Jazz Pharmaceuticals Inc.. Reporting peaked in 2019 at $1,401 and has fallen 95.3% since, to $66 in 2025.

$2,469in general payments, 2019–2025

Across 4 payments — averaging $617.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$2K
$520,504in research payments, 2019–2025

Across 194 payments — averaging $2683.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$363K
  • SK Life Science, Inc.$155K
  • Neuropace, Inc.$3K

What the payments were for

  • Consulting fees$2,35895%
  • Food & beverage$1115%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.4$2,469

How this compares

$2,469 in reported general payments places this provider in the 60th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
LevocarnitineLevocarnitine (With Sugar)14$1,391

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →